A report from Dr. Marc-Antoine Bagnoud*, Dianalabs in Geneva, Switzerland
Dianalabs is a mid-sized private lab founded in 1988 in Geneva, Switzerland, and part of the large swiss lab network Medisupport group with a total of 900 employees. Dr. Marc- Antoine Bagnoud, laboratory director of clinical chemistry at Dianalabs talked with us about the successful evaluation and implementation of the BÜHLMANN turbidimetric faecal pancreatic elastase assay, fPELA turbo in his laboratory.
Dianalabs in Geneva already applies BÜHLMANN fCAL® turbo, the turbidimetric assay for measuring faecal calprotectin, on their Roche cobas® c502 for over 5 years in routine. When the BÜHLMANN fPELA® turbo was launched in 2020, Dr. Bagnoud and his team also evaluated and implemented the immunoturbidimetric faecal pancreatic elastase assay in their laboratory.
